RECOMBINANT TRANSMEMBRANE DOMAIN-DEFICIENT STING AS BIOMIMETIC PROTEIN CARRIER FOR CGAMP ENHANCED CANCER IMMUNOTHERAPY
申请人:Northeastern University
公开号:US20210277077A1
公开(公告)日:2021-09-09
Disclosed are compositions comprising a fusion protein and a STING agonist, wherein the fusion protein comprises STINGΔTM protein fused to a cell-penetrating domain or a nanobody to deliver STING agonists. Also disclosed are methods of treating cancer, which is achieved by a administering said compositions.
BENZAMIDE DERIVATIVES AS CGAS-STING PATHWAY AGONISTS
申请人:Baruch S. Blumberg Institute
公开号:US20210347752A1
公开(公告)日:2021-11-11
Pharmaceutical compositions of the invention comprise functionalized benzamide derivatives useful as cyclic GMP-AMP synthase-Stimulator of interferon gene (cGAS-STING) pathway agonists, and useful for treating viral diseases and boost antitumor immunity.
[EN] BENZAMIDE DERIVATIVES AS CGAS-STING PATHWAY AGONISTS<br/>[FR] DÉRIVÉS DE BENZAMIDE UTILISÉS EN TANT QU'AGONISTES DE LA VOIE CGAZ-STING
申请人:BARUCH S BLUMBERG INST
公开号:WO2020072492A1
公开(公告)日:2020-04-09
Pharmaceutical compositions of the invention comprise functionalized benzamide derivatives useful as cyclic GMP-AMP synthase- Stimulator of interferon gene (cGAS-STING) pathway agonists, and useful for treating viral diseases and boost antitumor immunity.